Compare Autozone Inc (AZO) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Autozone Inc vs Novo Nordisk A/S — how do they compare? Autozone Inc trades at $3,025.08 (market cap $49.67B), while Novo Nordisk A/S trades at $45.8 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 4.2× Autozone Inc's market cap, and Novo Nordisk A/S pays a 3.81% dividend while Autozone Inc pays none. Which is the better fit depends on your goals.
| AZO | NVO | |
|---|---|---|
Market Cap | $49.67B | $207.85B |
Sector | Consumer Cyclical | Health |
52-Week High | $4.35K | $63.98 |
52-Week Low | $2.92K | $35.29 |
Enterprise Value | $62.05B | $222.55B |
Dividend Yield | — | 3.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Autozone Inc
AutoZone is the premier seller of aftermarket automotive parts, tools, and accessories to do-it-yourself customers in the United States. The company derives an increasing proportion of its sales from domestic commercial customers, although its presence in its home market is still dominated by its do-it-yourself operation, which accounts for nearly 75% of sales in country. AutoZone also has a growing presence in Mexico and Brazil. AutoZone had 6,767 stores in the U.S. (6,051), Mexico (664), and Brazil (52) as of the end of fiscal 2021.
Read more on AZO →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
